Biswajit Dubashi Selected Research

Biswajit Dubashi Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 04/2012
10	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2012
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2020 - 04/2012
5	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 10/2019
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 06/2011
4	Hodgkin Disease (Hodgkin's Disease) 04/2024 - 01/2017
4	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2022
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022 - 06/2016
3	Hand-Foot Syndrome 01/2022 - 04/2012
3	Leukemia 12/2021 - 06/2016
3	Febrile Neutropenia 10/2021 - 11/2018
3	Drug-Related Side Effects and Adverse Reactions 04/2021 - 01/2015
3	Thrombocytopenia (Thrombopenia) 01/2020 - 01/2015
2	Multiple Myeloma 03/2024 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2024 - 04/2022
2	Bone Resorption 09/2023 - 11/2021
2	Vomiting 04/2023 - 08/2020
2	Diarrhea 04/2023 - 12/2021
2	Glioma (Gliomas) 01/2023 - 01/2023
2	Ovarian Neoplasms (Ovarian Cancer) 09/2022 - 01/2021
2	Infections 10/2021 - 03/2014
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2021 - 02/2019
1	Chronic Disease (Chronic Diseases) 10/2023
1	Cachexia 10/2023
1	Anorexia 10/2023
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Weight Gain 10/2023
1	Body Weight (Weight, Body) 08/2023
1	Mucositis 04/2023
1	Constipation 04/2023
1	Chest Pain (Chest Pains) 04/2023
1	Fatigue 04/2023
1	Dyspnea (Shortness of Breath) 04/2023
1	Exanthema (Rash) 04/2023
1	Carcinogenesis 12/2022
1	Neoplasm Metastasis (Metastasis) 04/2022
1	Ovarian Epithelial Carcinoma 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Diabetes Mellitus 12/2021

Drug/Important Bio-Agent (IBA)

6	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 06/2011
5	Capecitabine (Xeloda)FDA Link 06/2023 - 10/2019
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2023 - 10/2019
4	Bleomycin (Blenoxane)FDA LinkGeneric 04/2021 - 03/2018
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
3	PlatinumIBA 09/2022 - 09/2014
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 03/2014
2	Bortezomib (Velcade)FDA Link 03/2024 - 01/2023
2	Tumor Biomarkers (Tumor Markers)IBA 01/2024 - 02/2019
2	AnthracyclinesIBA 10/2023 - 09/2023
2	taxaneIBA 10/2023 - 09/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 01/2023
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2023 - 01/2023
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2023
2	Etoposide (VP 16)FDA LinkGeneric 09/2022 - 04/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2020
2	EnzymesIBA 12/2021 - 07/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 11/2018
2	Hemoglobins (Hemoglobin)IBA 08/2021 - 02/2020
2	Hormones (Hormone)IBA 01/2021 - 07/2020
2	Letrozole (Femara)FDA LinkGeneric 01/2021 - 07/2020
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2020 - 03/2014
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 03/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2018
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020 - 03/2018
1	TNF Receptor-Associated Factor 3IBA 03/2024
1	antigen CYFRA21.1IBA 01/2024
1	Olanzapine (Zyprexa)FDA Link 10/2023
1	AntiemeticsIBA 09/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2023
1	Epirubicin (Ellence)FDA LinkGeneric 06/2023
1	AntioxidantsIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	CaspasesIBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	TeaIBA 01/2023
1	pomalidomideIBA 01/2023
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	N 30IBA 01/2022
1	GlycopeptidesIBA 12/2021
1	AntigensIBA 12/2021
1	Glutamate DehydrogenaseIBA 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2021
1	Denosumab FDA Link 11/2021

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 04/2024 - 10/2014
18	Therapeutics 03/2024 - 03/2014
5	Induction Chemotherapy 01/2023 - 09/2014
2	Radiotherapy 09/2017 - 06/2016
2	Medical Day Care (Partial Hospitalization) 01/2016 - 04/2015
1	Adjuvant Chemotherapy 11/2023
1	Chemoradiotherapy 11/2023
1	Platelet Transfusion (Blood Platelet Transfusions) 08/2023
1	Stem Cell Transplantation 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Neoadjuvant Therapy 04/2022
1	Drug Tapering 01/2022
1	Treatment Delay 01/2022